Exploring Potential Proteomic Biomarkers for Prognosis of Infective Endocarditis through Profiled Autoantibodies by an Immunomics Protein Array Technique
- 3 August 2020
- journal article
- research article
- Published by Forum Multimedia Publishing LLC in The Heart Surgery Forum
- Vol. 23 (5), E555-E573
- https://doi.org/10.1532/hsf.3017
Abstract
Though infective endocarditis (IE) is a life-threatening cardiac infection with a high mortality rate, the effective diagnostic and prognostic biomarkers for IE are still lacking. The aim of this study was to explore the potential applicable proteomic biomarkers for IE through the Immunome™ Protein Array system. The system was employed to profile those autoantibodies in IE patients and control subjects. Our results showed that interleukin-1 alpha (IL1A), nucleolar protein 4 (NOL4), tudor and KH domain-containing protein (TDRKH), G antigen 2B/2C (GAGE2), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and X antigen family member 2 (XAGE2) are highly differentially-expressed among IE and non-IE control. Furthermore, bactericidal permeability-increasing protein (BPI), drebrin-like protein (DBNL), signal transducing adapter molecule 2 (STAM2), cyclin-dependent kinase 16 (CDK16), BAG family molecular chaperone regulator 4 (BAG4), and nuclear receptor-interacting protein 3 (NRIP3) are differentially-expressed among IE and healthy controls. On the other hand, those previously identified biomarkers for IE, including erythrocyte sedimentation rate, C-reactive protein, rheumatoid factor, procalcitonin, and N-terminal-pro-B-type natriuretic peptide demonstrated only minor significance. With scientific rationalities for those highly differentially-expressed proteins, they could serve as potential candidates for diagnostic biomarkers of IE for further analysis.Keywords
This publication has 15 references indexed in Scilit:
- 2015 ESC Guidelines for the management of infective endocarditisEuropean Heart Journal, 2015
- 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive SummaryJournal of the American College of Cardiology, 2014
- HIP-55/DBNL-dependent regulation of adrenergic receptor mediates the ERK1/2 proliferative pathwayMolecular BioSystems, 2014
- Inflammatory parameters and prediction of prognosis in infective endocarditisBMC Infectious Diseases, 2013
- Antibiotic Modulation of the Plasminogen Binding Ability of Viridans Group StreptococciAntimicrobial Agents and Chemotherapy, 2012
- Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)European Heart Journal, 2009
- Pro-inflammatory cytokines IL6, TNF-α, IL1β, procalcitonin, lipopolysaccharide binding protein and C-reactive protein in infective endocarditisJournal of Infection, 2007
- Pathology and pathogenesis of infective endocarditis in native heart valvesCardiovascular Pathology, 2006
- The truth about antibioticsInternational Journal of Medical Microbiology, 2006
- Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of CardiologyJournal of the American Society of Echocardiography, 2005